We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hanmi

News List

Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide" prnasia
June 30, 2021
Hanmi Pharmaceutical recently announced that its new, long-acting diabetes biologic drug, efpeglenatide, was shown to significantly reduce incidences of major adverse cardiovascular events (MACE) and kidney disease in the results of its global ...
Syntekabio, Hanmi to Co-Develop COVID-19 Treatments Using Drug Repurposing Technologies americanpharmaceuticalreview
January 27, 2021
Syntekabio and Hanmi Science have entered into a strategic collaboration to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs prnasia
January 19, 2021
Hanmi Pharmaceutical Co., Ltd. plans to create a global R&D achievement based on innovations of inflammation–fibrosis treatment, Triple-acting new drug for NASH (non-alcoholic steatohepatitis) treatment as well as various other innovations in ...
Top Korean pharma companies increase their R&D spending in H1 biospectrumasia
August 17, 2017
Regulatory filings of 15 listed pharmaceutical firms showed 10 having upped their R&D expenditures in the January-June period from a year ago